Regulation of IL-2 production in Jurkat cells by Dictyostelium-derived factors

Life Sciences

Volumn 85, Issue 11-12, 2009, Pages 438-443

  Takahashi, Katsunori ^a   Murakami, Masami ^a   Hosaka, Kohei ^b   Kikuchi, Haruhisa ^c   Oshima, Yoshiteru ^c   Kubohara, Yuzuru ^b  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Dictyostelium; DIF; Differentiation inducing factor; Immunosuppressive drug; Interferon ; Interleukin 2; Jurkat cells

Indexed keywords

CONCANAVALIN A; CYCLOSPORIN A; DIFFERENTIATION INDUCING FACTOR; GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA; TACROLIMUS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DICTYOSTELIUM DISCOIDEUM; DRUG STRUCTURE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CONCANAVALIN A; DICTYOSTELIUM; GLUCOSE; HUMANS; INDICATORS AND REAGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; JURKAT CELLS; K562 CELLS; LUCIFERASES; MICE; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR AP-1;

ACRASIDA; DICTYOSTELIUM; DICTYOSTELIUM DISCOIDEUM; MAMMALIA;

EID: 69349105301     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.07.008     Document Type: Article

References (37)

1. Aherne S.A., and O'Brien N.M. Modulation of cytokine production by plant sterols in stimulated human Jurkat T cells. Molecular Nutrition & Food Research 52 6 (2008) 664-673
2. Akaishi E., Narita T., Kawai S., Miwa Y., Sasaguri T., Hosaka K., and Kubohara Y. Differentiation-inducing factor-1-induced growth arrest of K562 leukemia cells involves the reduction of ERK1/2 activity. European Journal of Pharmacology 485 1-3 (2004) 21-29
3. Allison A.C. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 47 2-3 (2000) 63-83
4. Asahi K., Sakurai A., Takahashi N., Kubohara Y., Okamoto K., and Tanaka Y. DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells. Biochemical and Biophysical Research Communications 208 3 (1995) 1036-1039
5. 2+, calcineurin, and NF-AT. Cell 96 5 (1999) 611-614
6. Dempster D.W. Bone histomorphometry in glucocorticoid-induced osteoporosis. Journal of Bone and Mineral Research 4 2 (1989) 137-141
7. Fung J.J., Alessiani M., Abu-Elmagd K., Todo S., Shapiro R., Tzakis A., Vanthiel D., Armitage J., Jain A., Mccauley J., Selby R., and Starzl T.E. Adverse effects associated with the use of FK506. Transplantation Proceedings 23 6 (1991) 3105-3108
8. Gokan N., Kikuchi H., Nakamura K., Oshima Y., Hosaka K., and Kubohara Y. Structural requirements of Dictyostelium differentiation-inducing factors for their stalk-cell-inducing activity in Dictyostelium cells and anti-proliferative activity in K562 human leukemic cells. Biochemical Pharmacology 70 5 (2005) 676-685
9. Griffith J.P., Kim J.L., Kim E.E., Sintchak M.D., Thomson J.A., Fitzgibbon M.J., Fleming M.A., Caron P.R., Hsiao K., and Navia M.A. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 82 3 (1995) 507-522
10. Hayashi K., Ishizuka S., Yokoyama C., and Hatae T. Attenuation of interferon-γ mRNA expression in activated Jurkat T cells by exogenous zinc via down-regulation of the calcium-independent PKC-AP-1 signaling pathway. Life Sciences 83 1-2 (2008) 6-11
11. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes & Development 18 18 (2004) 2195-2224
12. Kanai M., Konda Y., Nakajima T., Izumi Y., Kanda N., Nanakin A., Kubohara Y., and Chiba T. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK dependent pathway. Oncogene 22 4 (2003) 548-554
13. Kay R.R., Berks M., and Traynor D. Morphogen hunting in Dictyostelium discoideum. Development 107 Supplement (1989) 81-90
14. Kay R.R., Flatman P., and Thompson C.R.L. DIF signalling and cell fate. Seminer in Cell and Developmental Biology 10 6 (1999) 577-585
15. Kikuchi H., Ishiko S., Oshima Y., Gonkan N., Hosaka K., and Kubohara Y. Biological activities of novel derivatives of DIF-1 isolated from Dictyostelium. Biochemical and Biophysical Research Communications 377 3 (2008) 1012-1017
16. Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A., Tempczyk C.T., Kalish V.J., Tucker K.D., Showalter R.E., Moomow E.W., Gastinel L.N., Habuka N., Chen X., Maldonado F., Barker J.E., Bacquet R., and Villafranca J.E. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378 6557 (1995) 641-644
17. Kitahara K., and Kawai S. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Current opinion in rheumatology 19 3 (2007) 238-245
18. Kobayashi T., Momoi Y., and Iwasaki T. Cyclosporin A inhibits the mRNA expressions of IL-2, IL-4 and IFN-γ, but not TNF-α, in canine mononuclear cells. Journal of Veterinary Medical Science 69 9 (2007) 887-892
19. Kubohara Y. DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. Biochemical and Biophysical Research Communications 236 2 (1997) 418-422
20. Kubohara Y. Effects of differentiation-inducing factors (DIFs) of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent. European Journal of Pharmacology 381 1 (1999) 57-62
21. Kubohara Y., and Hosaka K. The putative morphogen, DIF-1, of Dictyostelium discoideum activates Akt/PKB in human leukemia K562 cells. Biochemical and Biophysical Research Communications 263 3 (1999) 790-796
22. Kubohara Y., Kikuchi H., and Oshima Y. Exploitation of the derivatives of Dictyostelium differentiation-inducing factor-1, which promote glucose consumption in mammalian cells. Life Sciences 83 17-18 (2008) 608-612
23. Kubohara Y., Kimura C., and Tatemoto K. Putative morphogen, DIF, of Dictyostelium discoideum induces apoptosis in rat pancreatic AR42J cells. Development, Growth & Differentiation 37 6 (1995) 711-716
24. Kubohara Y., Saito Y., and Tatemoto K. Differentiation-inducing factor of D. discoideum raises intracellular calcium concentration and suppresses cell growth in rat pancreatic AR42J cells. FEBS Letters 359 2-3 (1995) 119-122
25. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., and Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 4 (1991) 807-815
26. Masento M.S., Morris H.R., Taylor G.W., Johnson S.J., Skapski A.C., and Kay R.R. Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues. The Biochemical Journal 256 1 (1988) 23-28
27. Morris H.R., Taylor G.W., Masento M.S., Jermyn K.A., and Kay R.R. Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature 328 6133 (1987) 811-814
28. Morris H.R., Masento M.S., Taylor G.W., Jermyn K.A., and Kay R.R. Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum. The Biochemical Journal 249 3 (1988) 903-906
29. Omata W., Shibata H., Nagasawa M., Kojima I., Kikuchi H., Oshima Y., Hosaka K., and Kubohara Y. Dictyostelium differentiation-inducing factor-1 induces glucose transporter 1 translocation and promotes glucose uptake in mammalian cells. FEBS Journal 274 13 (2007) 3392-3404
30. Penfornis A., and Kury-Paulin S. Immunosuppressive drug-induced diabetes. Diabetes & Metabolism 32 5 Pt 2 (2006) 539-546
31. Shimizu K., Murata T., Tagawa T., Takahashi K., Ishikawa R., Abe Y., Hosaka K., and Kubohara Y. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an anti-tumor agent isolated from Dictyostelium. Cancer Research 64 7 (2004) 2568-2571
32. Takahashi-Yanaga F., Taba Y., Miwa Y., Kubohara Y., Watanabe Y., Hirata M., Morimoto S., and Sasaguri T. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells. The Journal of Biological Chemistry 278 11 (2003) 9663-9670
33. Takahashi-Yanaga F., Mori J., Matsuzaki E., Watanabe Y., Hirata M., Miwa Y., Morimoto S., and Sasaguri T. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells. The Journal of Biological Chemistry 281 50 (2006) 38489-38497
34. Tamura K. FK506: mechanism of immunosuppression and adverse-effects. The Journal of Toxicological Sciences 20 4 (1995) 477-479
35. Tanaka S., Akaishi E., Hosaka H., Okamura S., and Kubohara Y. Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochemical and Biophysical Research Communications 335 1 (2005) 162-167
36. Town C.D., Gross J.D., and Kay R.R. Cell differentiation without morphogenesis in Dictyostelium discoideum. Nature 262 5570 (1976) 717-719
37. Wurster B., and Kay R.R. New roles for DIF? Effects on early development in Dictyostelium. Developmental Biology 140 1 (1990) 189-195